A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Alta Bates Summit Medical Center, Berkeley, California, United States

  • City of Hope Cancer Center, Duarte, California, United States

  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica, California, United States

  • Yale Cancer Center, New Haven, Connecticut, United States

  • Georgetown University, Washington D.C., District of Columbia, United States

  • University of Miami, Coral Gables, Florida, United States

  • Indiana University, Indianapolis, Indiana, United States

  • University of Michigan Health System, Ann Arbor, Michigan, United States

  • St. Luke's Hospital, Chesterfield, Missouri, United States

  • Renown Regional Medical Center, Reno, Nevada, United States

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • Hematology Oncology Associates of Central New York, East Syracuse, New York, United States

  • University of Rochester, Rochester, New York, United States

  • Medical University of S. Carolina, Charleston, South Carolina, United States

  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

  • Renovatio Clinical - El Paso, El Paso, Texas, United States

  • Renovatio Clinical, The Woodlands, Texas, United States

  • University of Virginia, Charlottesville, Virginia, United States

  • West Virginia University, Morgantown, West Virginia, United States

  • Calvary Mater Newcastle, Waratah, New South Wales, Australia

  • Royal Adelaide Hospital, Adelaide, South Australia, Australia

  • Epworth Hospital, Richmond, Victoria, Australia

  • Hospital Sao Rafael - HSR, Salvador, Estado de Bahia, Brazil

  • ICTR Curitiba, Curitiba, Paraná, Brazil

  • Hospital Mae de Deus, Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital Paulistano, São Paulo, São Paulo, Brazil

  • Hospital Alemao Oswaldo Cruz, São Paulo, São Paulo, Brazil

  • Hospital A. C. Camargo, São Paulo, São Paulo, Brazil

  • Instituto D'Or Pesquisa e Ensino, São Paulo, São Paulo, Brazil

  • Americas Medical City, Rio de Janeiro, Brazil

  • Beneficencia Portuguesa de Sao Paulo, São Paulo, Brazil

  • Victoria Hospital - London Health Sciences Centre, London, Ontario, Canada

  • The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

  • Princess Margaret Cancer Center, Toronto, Ontario, Canada

  • Beijing Tong Ren Hospital, Capital Medical University, Beijing, China

  • The First Hospital of Jilin University, Changchun, China

  • West China Hospital of Sichuan University, Chengdu, China

  • Chongqing Cancer Hospital, Chongqing, China

  • Fujian Provincial Cancer Hospital, Fuzhou, China

  • Sun yat-sen University Cancer Center, Guangzhou, China

  • Guangxi Cancer Hospital of Guangxi Medical University, Nanning, China

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • The First Affiliated Hospital of China Medical University, Shenyang, China

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

  • Henan Cancer Hospital, Zhengzhou, China

  • Hopital Claude Huriez, Lille, France

  • Hopital Saint Eloi, Montpellier, France

  • CHU NANTES - Hôtel Dieu, Nantes, France

  • INSTITUT CURIE_SITE PARIS - Service d'Oncologie Médicale., Paris, France

  • Hopital Necker, Paris, France

  • Policlinico S.Orsola-Malpighi, Bologna, Emilia-Romagna, Italy

  • Humanitas Gavazzeni, Bergamo, Lombardy, Italy

  • Irccs Istituto Europeo Di Oncologia (IEO), Milan, Lombardy, Italy

  • SC Ematologia, AO SS. Antonio e Biagio e C. Arrigo, Alessandria, Piedmont, Italy

  • A.O. Città della Salute e della Scienza D - Osp. S. Giov. Battista Molinette, Turin, Piedmont, Italy

  • Auxilio Mutuo Cancer Center, San Juan, Puerto Rico

  • Chungnam National University Hospital, Daejeon, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Asan Medical Center, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Hospital Universitario Puerta del Mar, Cadiz, Cadiz, Spain

  • Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain

  • Hospital Universitari Vall d'Hebron, Barcelona, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Hospital General Universitario J.M Morales Meseguer, Murcia, Spain

  • Skånes University Hospital, Skånes Department of Onclology, Lund, Sweden

  • Akademiska sjukhuset, Onkologkliniken, Uppsala, Sweden

  • National Taiwan Universtiy Hospital, Taipei, Taiwan

  • Chang Gung Medical Foundation - Linkou, Taoyuan, Taiwan

  • NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

  • Lincolnshire County Hospital, Lincoln, United Kingdom

  • University College London Hospital, London, United Kingdom

  • Christie Hospital Nhs Trust, Manchester, United Kingdom

  • Oxford Churchill Hospital, Oxford, United Kingdom

  • Derriford Hospital, Plymouth, United Kingdom

Study leads
  • Clinical Trials

    Study Director

    Hoffmann-La Roche